Harvard Bioscience Inc.

Harvard Bioscience Inc.

HBIO

Get informed when a big investor buys or sells

+ Follow
Market Cap$35.86M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Harvard Bioscience Inc.Harvard Bioscience Inc.-3.4--140%0.46.4
$-3.24

Current Fair Value

140.7% downside

Overvalued by 140.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$35.86 Million
Enterprise Value$77.16 Million
Dividend Yield$- (-)
Earnings per Share$-12.8
Beta1.53
Outstanding Shares4,526,000

Return

Return on Equity-140.36%ROE
Return on Assets-13.65%
Return on Invested Capital97.04%

Valuation & Multiples

P/E Ratio-3.42P/E Ratio
PEG-12.42PEG
Price to Sales0.42Price to Sales
Price to Book Ratio7.96Price to Book Ratio
Enterprise Value to Revenue0.88
Enterprise Value to EBIT1.54
Enterprise Value to Net Income-8
Total Debt to Enterprise0.62
Debt to Equity6.44Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectation
Revenue Estimate
$21.45 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.17
Average shareholder expectation
Revenue Estimate
$21.80 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %29.90%▼ 5.55%
Total Invested$8.32M▲ 7.72%
Investors Holding34▼ 2.00%

ESG Score

No data

About Harvard Bioscience Inc.